The Organization

About us Membership (28226+) Basic Free! Professional New! Hosted groups (435) Bioinformatics courses Core Facility Career Center Wiki New! Newsletter New! Franklin Award Sponsorship Contribute

Research

Online databases EST clusters Immigrant genes Leukemia genes p53 tumor protein gene Pancreatic cancer genes Staph. aureus microarrays TB drug targets Acronyms Online analysis tools COMBOSA3D: Molecule coloring JaMBW: Mol. Biol. workbench PeCoP: Conserved positions PrimerX: Mutagenic primers Savvy: Plasmid map drawing SeWeR: Sequence analysis Sequence Extractor SMS 2: Sequence manipulation Links to Linux software All information groups

Development

Group hosting All software projects FTP repository SVN repository CVS repository Mailing lists

Education

New! Bioinformatics courses Bioinformatics FAQ

Store

Bioinformatics bookstore

Forums

News & Commentary Submit Archives Subscribe Jobs Forum (Career Center) Submit Archives Subscribe Bulletin Board Mailing list Archives Bioclusters Mailing list Archives Biodevelopers Mailing list Archives Molecular visualization Mailing list Archives

Other resources

BioMail BioBanner

News & Commentary

New York Times: Celera to Charge Other Companies to Use Its Genome Data Submitted by Gary Van Domselaar; posted on Sunday, December 10, 2000 "A company that deciphered the human genome has just submitted a paper for publication. But, in a highly unusual move, the company will not be adhering to the customary practice of simultaneously depositing its gene sequence data in a public repository freely available to all. Instead, the company, Celera Genomics, will put the data on its Web site, making them available to researchers free and to companies for a fee. The arrangement, announced by Celera and the editor of the journal Science, who said the paper would be published early next year, highlights the tricky financial issues that accompany the new era of genome research. Celera wants to sell its data. But scientific journals are committed to making all data related to its papers public. So how, Science's editors had asked, could they satisfy these conflicting goals? And did they want to set a precedent?" Full Story (Requires Free Registration): [link] Science Announces Plan for Ensuring Access to Celera Human Genome Sequence Data: [link]

Discussion Forums: New York Times: Celera to Charge Other Companies to Use Its Genome Data

Expanded View | Monitor Forum | Save Place | Post | Admin

Start a new thread:

You have to be logged in to post a reply.